- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
Posted on 1/7/21 at 10:25 pm to jmcwhrter
This kinda blows but looking more and more like everyday my put is gonna execute
Posted on 1/11/21 at 2:53 pm to bayoubengals88
Finally starting to wake back up
Posted on 1/11/21 at 2:55 pm to GAFF
Well, times almost up. Added to my position this morning
Posted on 1/11/21 at 4:32 pm to castorinho
quote:I added a few hundred dollars worth
Well, times almost up. Added to my position this morning
I’ve done all the damage I can do (within reason).
Posted on 1/11/21 at 4:33 pm to bayoubengals88
Volume today indicates plenty are thinking the same. Almost 5x avg daily volume
Posted on 1/11/21 at 4:49 pm to cuyahoga tiger
quote:Yes, today was a great indicator with steady high volume and a steady all day increase.
Volume today indicates plenty are thinking the same. Almost 5x avg daily volume
Demand is clearly ramping up.
This post was edited on 1/11/21 at 4:50 pm
Posted on 1/11/21 at 8:51 pm to bayoubengals88
Updated title for prospective investors...
It’s above $14 today after solid gains.
Tomorrow will indicate whether this will continue to run this week. It should, but $15 options expire on the 15th and we know how that can go...
Regardless, FDA approval should take us back to a minimum of $20.
It’s above $14 today after solid gains.
Tomorrow will indicate whether this will continue to run this week. It should, but $15 options expire on the 15th and we know how that can go...
Regardless, FDA approval should take us back to a minimum of $20.
This post was edited on 1/11/21 at 9:37 pm
Posted on 1/11/21 at 9:13 pm to bayoubengals88
quote:
should, but $15 options expire on the 15th and we know how that can go...
Regardless, FDA approval should take is back to a minimum of $20.
I'm sad my 14s not gonna execute.
Posted on 1/12/21 at 5:51 pm to bayoubengals88
quote:
Regardless, FDA approval should take us back to a minimum of $20.
My life would improve if that happened
Posted on 1/12/21 at 6:18 pm to GAFF
Considering buying Feb 20c now. Sponsored by thst put I sold.
In some ways I'm sad about fda news this thing has made me money on so many different trades on the way
In some ways I'm sad about fda news this thing has made me money on so many different trades on the way
Posted on 1/12/21 at 6:18 pm to Nguyener
quote:
My life would improve if that happened
what’s your basis?
Posted on 1/12/21 at 6:20 pm to oklahogjr
quote:It’ll continue to have ups and downs.
In some ways I'm sad about fda news this thing has made me money on so many different trades on the way
Can someone inform me about the 2037 labeling? Specifically why it’s uncertain and why it’s important...
Posted on 1/12/21 at 7:03 pm to bayoubengals88
quote:you're the expert on this thing
Can someone inform me about the 2037 labeling? Specifically why it’s uncertain and why it’s important...
Posted on 1/12/21 at 7:10 pm to bayoubengals88
I saw this on Stocktwits earlier today.
"If the dosing that Aurinia has patented is put on the
label, that secures their dosing until 2037 from 2027. Generics can still be made in 2027, but can’t use the patented dose and would need to go through trials."
It's unlikely (I believe) that another company would go through trials just to make a generic. Therefore, if the 2037 labeling gets approved, the value of AUPH would be considerably more as it would not face any potential generic competition for an additional 10 years.
As to why it's uncertain, the only thing I've been able to gather is that no matter how good the product, nothing is certain in biotech/pharmaceuticals.
"If the dosing that Aurinia has patented is put on the
label, that secures their dosing until 2037 from 2027. Generics can still be made in 2027, but can’t use the patented dose and would need to go through trials."
It's unlikely (I believe) that another company would go through trials just to make a generic. Therefore, if the 2037 labeling gets approved, the value of AUPH would be considerably more as it would not face any potential generic competition for an additional 10 years.
As to why it's uncertain, the only thing I've been able to gather is that no matter how good the product, nothing is certain in biotech/pharmaceuticals.
Posted on 1/12/21 at 7:21 pm to bayoubengals88
quote:
what’s your basis?
Been following this thread since the beginning and bought in big on a whim at the beginning
This post was edited on 1/12/21 at 7:48 pm
Posted on 1/12/21 at 7:30 pm to Volt
quote:
As to why it's uncertain, the only thing I've been able to gather is that no matter how good the product, nothing is certain in biotech/pharmaceuticals
I've read some things that, even if the FDA approves 2037, AUPH will need to be able to defend challenges to that in court
Posted on 1/12/21 at 7:42 pm to jmcwhrter
Soo are we still positioned for blast off or..
Popular
Back to top
Follow TigerDroppings for LSU Football News